Lee Soo-Hyeon, Shin Dong-Jun, Kim Sang-Ki
Department of Integrated Life Science and Technology, Kongju National University, Yesan-eup, Yesan-gun, Chungnam 340-702, Republic of Korea; Department of Laboratory and Companion Animal Science, College of Industrial Science, Kongju National University, Yesan-eup, Yesan-gun, Chungnam 340-702, Republic of Korea.
Department of Laboratory and Companion Animal Science, College of Industrial Science, Kongju National University, Yesan-eup, Yesan-gun, Chungnam 340-702, Republic of Korea.
Vet Immunol Immunopathol. 2015 May 15;165(1-2):1-13. doi: 10.1016/j.vetimm.2015.04.002. Epub 2015 Apr 8.
Interleukin-15 (IL-15) is a pleiotropic cytokine that plays a pivotal role in both innate and adaptive immunity. IL-15 is also a promising cytokine for treating cancer. Despite the growing importance of the clinical use of IL-15 for immunotherapy, no attempts have been made to generate a recombinant canine IL-15 (rcIL-15) and to examine its effects on the antitumor activities of immune effector cells in dogs. Here, we generated an rcIL-15 protein consisting of Asn-49-Ser-162 with a C-terminal His tag and examined its functions ex vivo in terms of the proliferation and antitumor effects on canine non-B, non-T, large granular natural killer (NK) cells. Non-B, non-T, large granular NK cells rapidly expanded in response to stimulation with rcIL-15 in the presence of IL-2, and a majority of the cells that selectively expanded over 21 days exhibited a CD3(-)CD5(-)CD4(-)CD8(+/-)CD21(-) phenotype. Purified rcIL-15 significantly enhanced the expansion rate of canine NK cells derived from peripheral blood mononuclear cells compared to human IL-15, or culture in the absence of IL-15 for 21 days (p<0.05). Purified rcIL-15 was superior at enhancing the effector function of NK cells compared to human IL-15. The cytotoxic activity against canine thyroid adenocarcinoma (CTAC) cells, interferon-γ production, and the mRNA expression levels of perforin and granzyme B of expanded NK cells cultured with rcIL-15 were significantly elevated compared to those cultured with human IL-15 or without IL-15 (p<0.05). Intravenous administration of rcIL-15 significantly increased the numbers of lymphocytes in the peripheral blood of dogs on days 6, 8, and 11 after injection compared to numbers before administration (p<0.05). The results of this study suggest that the rcIL-15 protein, consisting of Asn-49-Ser-162, enhanced the proliferation and antitumor effects of canine NK cells and promoted the generation of lymphocytes in dogs.
白细胞介素-15(IL-15)是一种多效细胞因子,在固有免疫和适应性免疫中均发挥关键作用。IL-15也是一种有前景的癌症治疗细胞因子。尽管IL-15在免疫治疗临床应用中的重要性日益增加,但尚未有人尝试制备重组犬IL-15(rcIL-15)并研究其对犬免疫效应细胞抗肿瘤活性的影响。在此,我们制备了一种由Asn-49-Ser-162组成并带有C端His标签的rcIL-15蛋白,并在体外研究了其对犬非B、非T大颗粒自然杀伤(NK)细胞增殖和抗肿瘤作用方面的功能。在有IL-2存在的情况下,非B、非T大颗粒NK细胞对rcIL-15刺激迅速扩增,并且在21天内选择性扩增的大多数细胞呈现CD3(-)CD5(-)CD4(-)CD8(+/-)CD21(-)表型。与人类IL-15或在无IL-15的情况下培养21天相比,纯化的rcIL-15显著提高了源自外周血单个核细胞的犬NK细胞的扩增率(p<0.05)。与人类IL-15相比,纯化的rcIL-15在增强NK细胞效应功能方面更具优势。与用人类IL-15培养或无IL-15培养的情况相比,用rcIL-15培养的扩增NK细胞对犬甲状腺腺癌(CTAC)细胞的细胞毒性活性、干扰素-γ产生以及穿孔素和颗粒酶B的mRNA表达水平均显著升高(p<0.05)。与注射前相比,静脉注射rcIL-15显著增加了注射后第6、8和11天犬外周血中的淋巴细胞数量(p<0.05)。本研究结果表明,由Asn-49-Ser-162组成的rcIL-15蛋白增强了犬NK细胞的增殖和抗肿瘤作用,并促进了犬体内淋巴细胞的生成。